Background : In ter ven tion ad her ence and trial re ten tion are chal leng ing for clin i cal tri als test ing in ten sive behav ioral in ter ven tions. Op er a tional con straints or trial de signs may pre clude us ing ef fec tive re ten tion strategies such as fi nan cial in cen tives. We ex am ined whether im ple ment ing pre -enrollment ori en ta tion ses sions was as so ci ated with higher in ter ven tion ad her ence and re ten tion in a prag matic clin i cal trial. Methods : The trial tested an in ten sive be hav ioral in ter ven tion for pa tients with chronic pain on long -term opioids. Ori en ta tion ses sions were im ple mented two years into trial re cruit ment at one site. Held be fore in formed con sent and ran dom iza tion, these manda tory, group -based ori en ta tion ses sions pro vided trial specifics, explained re search meth ods prin ci ples, and lever aged mo ti va tional in ter view ing tech niques. Us ing a pre -post design and mul ti vari ate mod els, we as sessed ad her ence (num ber of in ter ven tion meet ings at tended) and re tention (com pleted quar terly pain as sess ments over 12 months) be fore (04/ 2014 -12/2015; n = 209) and af ter (01/ 2016 -02/2017; n = 258) im ple men ta tion. Also, we eval u ated whether ses sion im ple men ta tion af fected the pro por tion and char ac ter is tics of en rolled pa tients. Results : Af ter im ple ment ing ori en ta tion ses sions, pa tients had higher in ter ven tion ad her ence than be fore (M = 7.6, SD = 3.8 vs. M = 5.6, SD = 4.5, re spec tively; mean dif fer ence = 2.0, 95% CI [0.9, 3.2], p = .001), and 2.8 times greater odds of com plet ing quar terly as sess ments (95% CI [1.3, 5.8], p = .007). Fewer pa tients en rolled af ter im ple ment ing ses sions than be fore (38.1% vs. 70.8%, 95% CI [26.4, 39.1], p < .001), with no dif fer ences in pa tient char ac ter is tics. Conclusions : Im ple ment ing ori en ta tion ses sions dur ing re cruit ment may be use ful for pro mot ing trial ad her ence and re ten tion. To en sure en roll ment goals are met, tar get pop u la tion size and bar ri ers af fect ing pa tients' ability to at tend ori en ta tion ses sions should be con sid ered, es pe cially for pa tients with com plex med ical con ditions. Clinical trials registration number : NC T02113592.
. Introduction
Clin i cal tri als of ten face chal lenges with in ter ven tion ad her ence and trial re ten tion, es pe cially tri als that re quire sub stan tial pa tient com mit ment and test in ten sive be hav ioral in ter ven tions [ 1 ] . Frequently, re searchers grap ple with dif fer en tial re ten tion be tween study arms or among cer tain sub pop u la tions. In a re cent meta -analysis of health be hav ior tri als, in ter ven tion par tic i pants had lower re ten tion than con trol par tic i pants, pos ing threats to in ter nal va lid ity [ 2 ] . Further, par tic i pants' ex pe ri ences in ei ther trial arm could af fect re tention both pos i tively and neg a tively. In ter ven tion par tic i pants might feel ob lig ated to com plete a trial be cause they re ceived free treatment, or they may drop out due to frus tra tion with poor out comes. Con trol par tic i pants may drop out if they are min i mally com mit ted to the trial given low in volve ment in ac tiv i ties. With out suc cess ful engage ment and re ten tion of all re search par tic i pants, the ef fec tive ness and gen er al iz abil ity of an in ter ven tion can not be de ter mined and resources are po ten tially wasted [ 3 , 4 ] .
Ef fec tive strate gies to ad dress ad her ence and re ten tion, such as pro vid ing fi nan cial in cen tives, us ing study data bases to track par tic ipants, and help ing par tic i pants over come par tic i pa tion bar ri ers by offer ing trans porta tion vouch ers may not al ways be fea si ble [ 5 , 6 ] . Rather, prag matic clin i cal tri als take place within real -world clin i cal set tings so in cen tives are rarely used, data col lec tion is of ten lim ited to elec tronic health records, and as sis tance gen er ally mim ics that of clin i cal prac tice [ 7 ] . Thus, ad her ence and re ten tion strate gies are criti cally needed for prag matic tri als, and could also in form clin i cal practice.
One po ten tial strat egy is con duct ing pre -enrollment ori en ta tion ses sions dur ing trial re cruit ment, used to date in be hav ioral weightmanagement ef fi cacy tri als and a chronic dis ease self -management pro gram [ 8 , 9 ] . In the Fresh Start weight -management trial [ 10 ] , in terac tive, group -based ori en ta tion ses sions, orig i nally de vel oped by Gold berg and Kier nan [ 8 ] , were held prior to ob tain ing in formed consent. The ses sions pro vided trial specifics, ex plained key re search meth ods, and lever aged mo ti va tional in ter view ing tech niques to diffuse po ten tial par tic i pant am biva lence about par tic i pa tion. As trial reten tion was 93% at 18 months [ 10 ] , pre -enrollment ori en ta tion sessions show promise for pro mot ing re ten tion. How ever, re ten tion data were ob ser va tional as there was no con trol group and all trial par tic ipants at tended an ori en ta tion ses sion. In the widely -implemented Chronic Dis ease Self -Management Pro gram in which more than 100,000 U S. adults par tic i pated, "Ses sion Zero" in for ma tion ses sions were held prior to the pro gram's six work shops at some com mu nity sites. Work shop at ten dance was higher at sites when Ses sion Zero was of fered than when it was not [ 9 ] . How ever, the di rect ef fect of Ses sion Zero on par tic i pant ad her ence could not be de ter mined be cause at tendance was not tracked at the par tic i pant level [ 9 ] .
Pain Pro gram for Ac tive Cop ing and Train ing (PPACT) was a pragmatic clin i cal trial that eval u ated an in ten sive be hav ioral in ter ven tion for pa tients with chronic pain on long -term opi oids. To ad dress initially low rates of ad her ence and re ten tion, PPACT in tro duced in ter active, group -based pre -enrollment ori en ta tion ses sions ap prox i mately two years into the trial. The de layed im ple men ta tion of the ori en tation ses sions of fered the op por tu nity to as sess whether these ses sions were as so ci ated with higher in ter ven tion ad her ence and trial re tention. Ad di tion ally, we eval u ated whether im ple men ta tion af fected the pro por tion of el i gi ble pa tients who en rolled and ex plored whether their de mo graphic and clin i cal char ac ter is tics dif fered from the tar get pop u la tion.
. Methods

1 . Data source and study population
The data source is the PPACT prag matic clin i cal trial, de scribed above. The core of the PPACT in ter ven tion is 12 weekly group meetings, which par tic i pants were ex pected to at tend. The in ter ven tion group meet ings pro vided train ing on how to adopt ev i dence -based pain cop ing skills and in crease phys i cal ac tiv ity (de scribed else where [ 11 ] ). Pa tients were en rolled (i.e., con sented and ran dom ized) in the prag matic trial for 12 months. Quar terly as sess ments con sisted of the PEG [ 12 , 13 ] , a val i dated 3 -item mea sure de rived from the short form of the Brief Pain In ven tory (BPI -SF) [ 14 , 15 ] . The PEG as sess ments were col lected via three dif fer ent mech a nisms to take ad van tage of au to mated op tions and in crease scal a bil ity for this prag matic trial, includ ing the pa tient elec tronic health record web por tal ( kp. org ), Kaiser's in ter ac tive voice re sponse phone sys tem, and via phone with a live per son [ 16 ] .
We im ple mented the ori en ta tion ses sions in Kaiser Per ma nente North west (KPNW) ( Fig. 1 ) , which was one of three trial sites. Here, us ing a pre -post study de sign and mul ti vari ate mod els, we as sessed inter ven tion ad her ence (num ber of in ter ven tion group meet ings attended) and re ten tion (com ple tion of quar terly pain as sess ments over 12 months) be fore (April 2014 -December 2015; n = 209) or af ter (Jan u ary 2016 -February 2017; n = 258) the PPACT trial im plemented ori en ta tion ses sions at KPNW. The KPNW In sti tu tional Re view Board pro vided over sight for all study ac tiv i ties.
2 . Rationale for implementing orientation sessions
The ra tio nale for im ple ment ing the ori en ta tion ses sions was twofold. First, ap prox i mately two years into the PPACT trial, in ter ven tion ad her ence at the KPNW site was low as al most 25% never at tended a sin gle in ter ven tion group meet ing and on av er age, only 85% of PPACT trial par tic i pants com pleted the low -burden 3 -item pain as sessment across all four fol low -up time points. In ter views with par tic ipants who had only at tended a few in ter ven tion group meet ings revealed they were con fused about the in ter ven tion and trial re quirements, which af fected their abil ity to ful fill trial com mit ments.
Sec ond, due to an ag gres sive Kaiser Per ma nente health care system -wide ef fort to ta per opi oids among pa tients with chronic pain on high doses of the med ica tion, which ac com pa nied the April 2016 release of the Cen ters for Dis ease Con trol (CDC) Guide line for Pre scribing Opi oids for Chronic Pain [ 17 ] , many in di vid u als in the PPACT trial tar get pop u la tion were re ceiv ing let ters alert ing them to changes in their pain med ica tion while they were be ing ap proached about trial par tic i pa tion. Nu mer ous pa tients whom we con tacted ex pressed concern about the an tic i pated changes in their pain med ica tion and misper ceived the op por tu nity to par tic i pate in the PPACT trial as be ing linked to or dri ven by the opi oid pre scrip tion changes. There fore, orien ta tion ses sions were also de vel oped and im ple mented as part of the re cruit ment process to try to ad dress po ten tial mis per cep tions.
3 . Recruitment protocols before and after implementing orientation sessions
Pa tients with ev i dence of a pain con di tion on long -term opi oid treat ment, based on elec tronic health records (EHR) data, were po tentially el i gi ble for the PPACT trial (de scribed else where [ 11 ] ). Through out the trial, po ten tially el i gi ble pa tients were first mailed an in for ma tional let ter and then con tacted by phone; dur ing the calls, research staff pro vided an overview of the trial, con ducted el i gi bil ity screen ing, and ad dressed ques tions. Be fore im ple ment ing the ori en tation ses sions, if pa tients were el i gi ble and in ter ested in the trial, follow -up phone calls were sched uled for two to three days later to conduct the in formed con sent. How ever, af ter im ple men ta tion, pa tients who were el i gi ble and in ter ested were in vited to at tend an in -person, hour -long ori en ta tion ses sion at their pri mary care clinic be fore de ciding to par tic i pate. Typ i cally, pa tients were of fered three dates and times for an ori en ta tion ses sion over the fol low ing month and chose one to at tend. They were sent a con fir ma tory email and re ceived a reminder phone call the day be fore. If pa tients at tended the ori en ta tion ses sion, they were con tacted by phone in the fol low ing week to de termine whether they wanted to en roll in the trial and, if ap pro pri ate, move for ward with the in formed con sent process.
4 . Orientation session overview
Mod eled af ter Gold berg and Kier nan [ 8 ] , the hour -long ori en ta tion ses sions were de signed for ap prox i mately 15 at ten dees to eas ily in teract and ask ques tions and were led by KPNW PPACT se nior re search staff. PPACT trial specifics in cluded out lin ing the ra tio nale for the prag matic study de sign; de scrib ing the two trial arms (PPACT in terven tion and usual care), in di vid ual PPACT be hav ioral in ter ven tion com po nents and the tri al's pri mary out come mea sure; and in de pendence of trial el i gi bil ity and par tic i pa tion from the KPNW sys temwide opi oid ta per ing ini tia tive. Re search meth ods prin ci ples in cluded ex plain ing the ra tio nale for ran dom iza tion and the method olog i cal im pact of poor re ten tion on trial con clu sions. Mo ti va tional in ter viewing tech niques ad dressed po ten tial par tic i pant am biva lence about trial par tic i pa tion and be hav ior change [ 8 ] . To pro mote sim i lar re ten tion by trial arm, the ori en ta tion ses sions em pha sized the equal im portance of data com ple tion by par tic i pants in both arms. To sup port partic i pants in mak ing an in formed de ci sion as to whether to par tic i pate in a prag matic clin i cal trial, the pre sen ter di vided the at ten dees into small groups of three to four peo ple to dis cuss the pros and cons of be ing or not be ing in the trial, and then left the room so at ten dees would feel free to dis cuss their opin ions. Upon the pre sen ter's re turn, each small group shared their pros and cons with the larger group, and the pre sen ter recorded all pros and cons on a flip chart or whiteboard, en gaged in re flec tive lis ten ing, and re mained neu tral re gard ing trial par tic i pa tion [ 8 ] . Fig. 2 sum ma rizes com mon pros and cons that emerged from these dis cus sions.
5 . Outcomes for this pre -post study design
Pri mary Out comes. We as sessed two pri mary out comes: in ter vention ad her ence (num ber of PPACT in ter ven tion group meet ings attended out of 12) and trial re ten tion (par tic i pant com ple tion of a pain as sess ment at each quar terly time point over 12 months). Sec ondary Out come . To as sess whether im ple ment ing ori en ta tion ses sions prior to ran dom iza tion af fected the pro por tion of el i gi ble patients who en rolled in the PPACT trial, we tracked the num ber of patients at three en roll ment stages be fore and af ter im ple ment ing ori enta tion ses sions: those mailed a re cruit ment let ter, those el i gi ble and in ter ested in the trial af ter the ini tial phone call, and those who enrolled (i.e., pro vided ver bal con sent and were ran dom ized).
Ex ploratory Out comes . In post -hoc analy ses, we ex plored whether im ple ment ing ori en ta tion ses sions af fected the sam ple char ac ter is tics of el i gi ble KPNW pa tients who en rolled in the PPACT trial rel a tive to the char ac ter is tics of the el i gi ble KPNW tar get pop u la tion who were ap proached be fore and af ter im ple ment ing the ori en ta tion ses sions. Char ac ter is tics in cluded the 19 de mo graphic and clin i cal char ac ter istics as sessed in the main PPACT prag matic trial that could have poten tially in flu enced the PPACT tri al's pri mary out come (pain im pact). Thus, not all char ac ter is tics may be rel e vant to the pri mary out comes of in ter est here (ad her ence and re ten tion) but pro vided a frame work for ex plo ration.
6 . Analyses
Pri mary out comes. To ex am ine whether im ple ment ing ori en ta tion ses sions was as so ci ated with higher in ter ven tion ad her ence (num ber of PPACT in ter ven tion group meet ings at tended dur ing the study period), we used a two -level hi er ar chi cal lin ear model (also known as mul ti level re gres sion, mixed model, or ran dom co ef fi cients re gres sion [ 18 -20 ] ) with one in de pen dent vari able -orientation ses sion (be fore/ af ter) and mod eled the clus ter ing of pa tients within their pri mary care provider as a ran dom ef fect. The ran dom ef fect ac counts for the in tr aclass cor re la tion of pa tients nested within providers, con sis tent with the over all PPACT trial clus ter ran dom iza tion. In a sec ond model, we con trolled for av er age daily dose of opi oid med ica tion (≥90 mor phine mil ligram equiv a lents daily/ or less) by adding it as an in de pen dent vari able. Be cause the dis tri b u tion of this count vari able did not fol low a neg a tive bi no mial dis tri b u tion that is typ i cal of count vari ables, we used an iden tity link and Guass ian dis tri b u tion (i.e., stan dard lin ear mixed model).
Level 1 Model: Adherence ij = B 0j + B 1j Orientation Sessions ij + r ij
Where Ad her ence ij is the mea sure for the i th per son nested within the j th provider, Ori en ta tion Ses sions is coded 0 for be fore, 1 for af ter for the i th per son nested within the j th provider, B 0j is the in ter cept for the j th provider, B 1j is the co ef fi cient as so ci ated with Ori en ta tion Ses sions for the j th provider, r ij is the ran dom er ror as so ci ated with the i th per son nested within the j th provider, γ 00 is the over all mean in ter cept, u 0j is the ran dom ef fect on the in ter cept of the j th provider, γ 10 is the over all mean slope.
To ex am ine whether im ple ment ing ori en ta tion ses sions was as so ciated with higher trial re ten tion (par tic i pant com ple tion of pain as sessment at each quar terly time point over 12 months), we used threelevel hi er ar chi cal gen er al ized lin ear mod els us ing a log link and bi nomial dis tri b u tion (also known as mul ti level lo gis tic re gres sion) that ac counted for the nest ing of re peated ob ser va tions (quar terly as sessments) within pa tients within providers. We eval u ated four mod els. All four mod els in cluded three in de pen dent pre dic tors -time (lin ear ef fect; Level 1), ori en ta tion ses sion (be fore/ af ter; Level 2), and trial arm (con trol/ in ter ven tion; Level 3) -as well as Level 2 (i.e., per son level) ran dom ef fects for the Level 1 in ter cepts and slope for time, and Level 3 (i.e., provider level) ran dom ef fects for the Level 2 in ter cept. The sec ond model also in cluded the in ter ac tion of time and ori en tation ses sion; the third model in cluded the in ter ac tion of time and trial arm; and the fourth model in cluded av er age daily dose of opi oid medica tion. 
is the in ter cept for the j th per son nested within the k th provider, π 1jk is the co ef fi cient as so ci ated with time for the j th per son nested within the k th provider, Time is the as sess ment pe riod for the i th ob ser va tion nested within the j th per son nested within the k th provider, e ijk is the ran dom er ror as so ci ated with the for the i th ob ser va tion nested within the j th per son nested within the k th provider, B 00k is the mean in tercept for the k th provider af ter ad just ing for Ori en ta tion Ses sions, B 01k =γ 010 is the co ef fi cient as so ci ated with Ori en ta tion Ses sions (0 =
Sec ondary out come. To eval u ate whether im ple ment ing ori en tation ses sions af fected the pro por tion of el i gi ble pa tients who en rolled in the trial, we con ducted a Chi -squared test to com pare the pro portion of po ten tially el i gi ble pa tients who en rolled (i.e., pro vided ver bal con sent and were ran dom ized) be fore and af ter im ple ment ing ori en tation ses sions.
Ex ploratory out comes. To ex plore whether im ple ment ing ori en tation ses sions af fected the de mo graphic and clin i cal char ac ter is tics of the pa tient sam ple who en rolled in the trial rel a tive to the char ac ter istics of the tar get pop u la tion of po ten tially el i gi ble KPNW pa tients during the same time pe ri ods (be fore and af ter im ple ment ing ori en ta tion ses sions), we con ducted a 2X2 ANOVA (for con tin u ous char ac ter is tics) or lo gis tic re gres sion (for cat e gor i cal char ac ter is tics) with two in depen dent pre dic tors -trial en roll ment (yes/ no) and ori en ta tion ses sion (no/ yes, i.e., be fore/ af ter) -and the in ter ac tion be tween the two predic tors. A sig nif i cant in ter ac tion term would sug gest that the ori en tation ses sions them selves con tributed to dif fer ences in de mo graphic or clin i cal char ac ter is tics of pa tients who en rolled be fore and af ter imple men ta tion, rather than changes in the tar get po ten tially el i gi ble pop u la tion over time. All analy ses were eval u ated us ing a two -tailed al pha level of 0.05 and 95% con fi dence in ter vals.
. Results
1 . Primary outcomes
In ter ven tion ad her ence . Af ter im ple ment ing ori en ta tion ses sions, PPACT par tic i pants had higher in ter ven tion ad her ence at the 12 PPACT group meet ings than be fore im ple ment ing ori en ta tion ses sions (M = 7.6, SD = 3.8 vs. M = 5.6, SD = 4.5, re spec tively; mean differ ence = 2.0, 95% CI [0.9, 3.2], p = .001). Con trol ling for av er age daily dose of opi oid med ica tion did not change re sults. In ad di tion, after im ple ment ing the ori en ta tion ses sions, the per cent age of en rolled PPACT par tic i pants who never at tended any of the 12 PPACT group meet ings at the KPNW site was lower than the per cent age of en rolled PPACT par tic i pants who never at tended any group meet ings be fore im ple ment ing ses sions, 9.4% -23.1%, re spec tively; dif ference = 13.7% (95% CI for the dif fer ence in these two pro por tions [4.2, 23.1], p = .004) ( Fig. 3 ) .
Trial re ten tion. Table 1 pre sents the un ad justed rates for com pleting the quar terly pain as sess ments by as sess ment time point. As there was an ICC of 0.65 for the per son level and a near -zero ICC for the provider level (<1.0 X10 30 ), we con ducted both the orig i nally spec ified three -level mul ti level lo gis tic re gres sion model as well as a more par si mo nious two -level model that ex cluded the ran dom ef fect of provider. Given the un sur pris ing iden ti cal re sults for re gres sion co ef fi - Fig. 3 . In ter ven tion groups at tended pre -& post -implementation of ori en ta tion ses sions. Table 1 Un ad justed re ten tion rates be fore and af ter im ple ment ing ori en ta tion ses sions by PPACT trial arm. cients and as so ci ated in fer en tial tests be tween the three -and twolevel mod els, we re port the more par si mo nious two -level re sults. Af ter im ple ment ing ori en ta tion ses sions, PPACT par tic i pants had 2.8 higher odds of com plet ing quar terly pain as sess ments than be fore im plement ing the ori en ta tion ses sions (95% CI [1.3, 5.8], p = .007). In the three re main ing mod els, there were no ef fects for time by ori en ta tion (p = .10), time by trial arm (p = .50) or av er age daily dose of opi oid med ica tion ≥90 MME (p = .92).
2 . Secondary outcome
Af ter im ple ment ing ori en ta tion ses sions, the pro por tion of pa tients who en rolled in the PPACT trial was lower than be fore im ple ment ing the ses sions, 38.1% (n = 258/ 678) vs. 70.8% (n = 209/ 295), re spectively (dif fer ence = 32.7%, 95% CI [26.4, 39.1], p < .001).
3 . Exploratory outcomes
In post -hoc analy ses, all but one of the 19 in ter ac tions for pa tient de mo graphic and clin i cal char ac ter is tics were not sig nif i cant, in di cating that any dif fer ences ob served be fore and af ter im ple ment ing the ori en ta tion ses sions may have been rep re sen ta tive of over all chang ing trends in the po ten tially el i gi ble KPNW tar get pop u la tion ap proached dur ing the two time pe ri ods, rather than the ori en ta tion ses sions ( Table 2 ). Only the in ter ac tion term for race was sig nif i cant, sug gesting that af ter im ple ment ing the ori en ta tion ses sions, a lower pro portion of pa tients who re ported a non -White race (Black, African Amer ican or Other) en rolled in the trial than be fore, 5.4% vs. 8.6% re spectively (in ter ac tion OR = 1.24, 95% CI [1.03, 1.51], p = .02). Clin i cal sig nif i cance of this in ter ac tion should be in ter preted in an ex ploratory con text in which a large num ber of tests were con ducted and that the in ter ac tion would not be sta tis ti cally sig nif i cant with ap pro pri ate correc tion for mul ti ple com par isons.
. Discussion
Im ple ment ing ori en ta tion ses sions was as so ci ated with higher atten dance at PPACT in ter ven tion group meet ings as well as higher PPACT re ten tion through the trial fol low -up pe riod as shown by higher pa tient com ple tion of quar terly as sess ments. How ever, improve ments in ad her ence and re ten tion in this prag matic clin i cal trial among pa tients with chronic pain came with a cost: over all en rollment rates dropped sub stan tially -al most a third -once at tend ing an ori en ta tion ses sion be came a re quired step in the trial en roll ment process.
Our find ings in di cate that ori en ta tion ses sions are an ef fec tive strat egy for pro mot ing ad her ence and re ten tion to an in ten sive health be hav ior in ter ven tion through a one -year trial pe riod. Used as the sole strat egy to ad dress these fac tors, as they were in the PPACT prag matic trial be cause other strate gies such as fi nan cial in cen tives were not feasi ble due to the prag matic trial de sign, these ori en ta tion ses sions resulted in re ten tion rates of 88% or higher at each fol low -up time point. This rate ex ceeds the av er age re ten tion rate of 80% ob served in sim i lar be hav ior change tri als [ 1 ] . Im por tantly, the ef fect of the ori enta tion ses sions did not ap pear to dif fer by trial arm, sug gest ing that hold ing these ses sions prior to en roll ment might be an ef fec tive strategy to pre vent dif fer en tial re ten tion by arm, which is com monly observed in health be hav ior tri als and sig nif i cantly com pro mises the abil ity to as sess an in ter ven tion's ef fec tive ness [ 2 ] . The ef fect of the ori en ta tion ses sions on PPACT group ad her ence was also pos i tive. By im ple ment ing the ori en ta tion ses sions, the PPACT trial achieved a PPACT in ter ven tion tar get goal, namely for pa tients to at tend the major ity of the 12 group meet ings. In deed, pa tients at tended an av er age of 7.6 group meet ings or 2 more meet ings than pa tients who par tic ipated be fore im ple ment ing ori en ta tion ses sions. In ad di tion, the percent age of pa tients who never at tended any group meet ings was cut in half. Af ter im ple ment ing the ori en ta tion ses sions, fewer than 1 in 10 pa tients never at tended any group meet ings whereas 1 in 4 pa tients never at tended any group meet ings be fore im ple ment ing the ori en tation ses sions. Table 2 Char ac ter is tics of KPNW PPACT trial par tic i pants be fore and af ter im ple ment ing ori en ta tion ses sions. The im pact of the ori en ta tion ses sions on en roll ment rates in the PPACT trial among pa tients with chronic pain was not triv ial and may have been due to sev eral fac tors. First, re quir ing at ten dance at the orien ta tion ses sion prior to en roll ment cre ated an ex tra step for el i gi ble and in ter ested pa tients to com plete be fore de cid ing whether to par tici pate, which could se lect for more mo ti vated pa tients. Sec ond, and per haps more rel e vant, are fac tors spe cific to the pop u la tion of chronic pain pa tients who were el i gi ble for the PPACT trial, as these pa tients typ i cally ex pe ri ence poor phys i cal func tion ing which can affect their abil ity to travel to and at tend in -person meet ings out side their homes. Third, the ma jor wide spread changes in pol icy and practice to re strict or ta per opi oid pre scrip tions for pa tients with chronic pain that oc curred na tion ally and within the KPNW health sys tem in early 2016 when the ori en ta tion ses sions were im ple mented could have un der cut the tar get pop u la tion's in ter est in en gag ing fur ther with the KPNW health care sys tem and their health care providers so as not to jeop ar dize or dis rupt their cur rent pain pre scrip tion lev els. There fore, fu ture tri als con sid er ing ori en ta tion ses sions need to en sure that en roll ment tar gets can be met even if only 35 -40% of those who are el i gi ble en roll. This in cludes con sid er ing the char ac ter is tics of the tar get pop u la tion from which par tic i pants are to be re cruited, es pecially for med ically com plex pa tients who face phys i cal and so cial bar ri ers when en gag ing with health care sys tems, as well as the size of the tar get pop u la tion, as ad di tional re cruit ment ef forts and el i gi bil ity screen ing may be nec es sary.
Given that ori en ta tion ses sions may be ef fec tive in pro mot ing adher ence in prag matic clin i cal tri als and re quire few re sources, it is pos si ble that they could be a use ful tool to both en gage pa tients and im prove the de liv ery of be hav ioral in ter ven tions and pro grams in clin i cal set tings. In fact, re quir ing ori en ta tion ses sions prior to en rollment in or com ple tion of a costly in ter ven tion is not un com mon in the de liv ery of clin i cal care [ 21 , 22 ] .
De spite the strengths of our study, it also had lim i ta tions. Although our de sign en abled a com par i son of those who en rolled be fore and af ter im ple men ta tion of the ori en ta tion ses sions, a stronger compar i son would have been a si mul ta ne ous con trol group who were not re quired to at tend the ori en ta tion ses sions, and a ran dom ized study de sign. In ad di tion, as a re sult of wide spread opi oid pre scrip tion taper ing, there were dif fer ences in the amount of opi oids taken by patients who en rolled in the trial be fore and af ter im ple men ta tion of the ori en ta tion ses sions. How ever, we ad dressed this po ten tial con founding by in clud ing av er age daily opi oid dose as a co vari ate in our models. Lastly, the lim ited racial and eth nic di ver sity of the trial pop u lation at the KPNW site pre vented us from be ing able to as sess dif ferences in ad her ence and re ten tion among racial and eth nic sub groups. Im por tantly, re cent re ports sug gest that those most im pacted by chronic pain are more likely to be racial and eth nic mi nori ties, as well as from lim ited fi nan cial means [ 23 ] . Hence, iden ti fy ing whether orien ta tion ses sions im pact par tic i pa tion and pro mote ad her ence and reten tion in tri als among dis ad van taged pop u la tions should be a fo cus of fu ture work.
. Conclusions
In sum mary, im ple ment ing ori en ta tion ses sions when re cruit ing for an in ten sive be hav ior change trial or clinic -based in ter ven tion can be a use ful strat egy for im prov ing ad her ence and re ten tion, es pe cially if other strate gies such as fi nan cial in cen tives can not be em ployed. If uti lized, con sid er a tion of tar get pop u la tion char ac ter is tics which may af fect abil ity to at tend an in -person ses sion, such as phys i cal and psychoso cial bar ri ers, should be ex plored to en sure en roll ment tar gets can be met.
In ad di tion, a large enough pop u la tion may be needed to meet enroll ment tar gets, as a smaller pro por tion of el i gi ble par tic i pants may choose to par tic i pate. In ter ac tive group -based ori en ta tion ses sions are a fea si ble and low re source ap proach to en sure par tic i pant en gagement and re ten tion.
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